You are here: Industry Insights > KB

News List

With Anlotinib Sold over RMB4 Billion in 2020, Which will be the Next Blockbuster of Sino Biopharmaceutical? PharmaSources/Caicai
May 31, 2021
Sino Biopharmaceutical has recently released its 2020 annual results, with total revenue of RMB23.647 billion, down 2.4% year on year, net profit attributable to the parent of RMB2.771 billion, up 0.3% year on year
A Better Anti-Influenza Solution: Roche’s Blockbuster New Drug Applied for Marketing in China PharmaSources/Xiaoyaowan
June 24, 2020
According to the website of the CDE on June 10, the marketing applications of Roche for its new drug Baloxavir Marboxil Tablets in China have been accepted by the CDE.
AXA and HKBN Deepen Collaboration with Launch of "HKBN SmartTraveller Plus" PR Newswire
December 11, 2024
AXA Hong Kong and Macau (AXA) and Hong Kong Broadband Network Limited (HKBN) have taken their collaboration another step forward by introducing "HKBN SmartTraveller Plus"
AskBio, Touchlight Restructure Former JV, Touchlight AAV contractpharma
February 08, 2022
Both parties benefit from co-exclusive rights to independently supply the Adeno-Associated Virus (AAV) market with doggybone DNA.
Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report prnasia
January 10, 2022
Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of its annual Drugs to Watch™ report...
Laekna Presents Vision and Strategy at NewYorkBIO/NYSE Emerging Company Showcase prnasia
December 27, 2021
Laekna was invited by NewYorkBIO and the New York Stock Exchange (NYSE) to present, as an emerging biotech company at the "Emerging Company Showcase" that was held earlier this month in New York.
Ping An's AI-driven AskBob Doctor Earns Top Scores in Diabetes Management Competition prnasia
December 08, 2021
Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that its AskBob Doctor, an artificial intelligence-driven consultation and treatment assistance tool...
AskBio’s Gene Therapy Gets Fast Track contractpharma
July 22, 2021
LION-101 is a recombinant adeno-associated virus (rAAV) based vector being developed as a one-time treatment for Limb-Girdle Muscular Dystrophy.
Krystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB105 for the Treatment of TGM-1 Associated Ichthyosis firstwordpharma
July 02, 2021
KRYS today announced updated results from the Phase 1/2 clinical trial evaluating topical administration of KB105 in patients with autosomal recessive congenital ichthyosis (ARCI) associated with mutations in the TGM1 gene.
Selexis, KBI Biopharma, Immatics Partner to Advance TCR Program contractpharma
July 01, 2021
Selexis SA and KBI Biopharma, both JSR Life Sciences companies, have signed service agreements with Immatics N.V., a clinical-stage biopharmaceutical company focused on T cell redirecting cancer immunotherapies.